Patents by Inventor Sergio Andre RODRIGUEZ APONTE

Sergio Andre RODRIGUEZ APONTE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SARS-CoV-2 antigens and uses thereof
    Patent number: 11872279
    Abstract: The present disclosure relates to, inter alia, variants of the receptor binding domain of a coronavirus (e.g., SARS-CoV-2) having increased immunogenicity and reduced aggregation, and the use of the RBD variants in methods for preventing infection of the coronavirus.
    Type: Grant
    Filed: October 28, 2021
    Date of Patent: January 16, 2024
    Assignee: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: J. Christopher Love, Sergio Andre Rodriguez Aponte, Neil Chandra Dalvie
  • NOVEL SARS-COV-2 ANTIGENS AND USES THEREOF
    Publication number: 20220133880
    Abstract: The present disclosure relates to, inter alia, variants of the receptor binding domain of a coronavirus (e.g., SARS-CoV-2) having increased immunogenicity and reduced aggregation, and the use of the RBD variants in methods for preventing infection of the coronavirus.
    Type: Application
    Filed: October 28, 2021
    Publication date: May 5, 2022
    Inventors: J. Christopher LOVE, Sergio Andre RODRIGUEZ APONTE, Neil Chandra DALVIE